Evidence map›Paper›PMID 37937227›Full record

ArticleGastroenterology research2023

COVID-19 Outcomes in Inflammatory Bowel Disease Hospitalized Patients: A Comprehensive Analysis Using the National Inpatient Sample.

Justin M Joseph, Anum Akhlaq, Rehmat Ullah Awan, Saleha Aziz, Moon Ryu, Asif Farooq, Karthik Gangu, Ehizogie Edigin, Abu Baker Sheikh

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Justin M JosephDepartment of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
Anum AkhlaqDepartment of Internal Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
Rehmat Ullah AwanDepartment of Internal Medicine, Ochsner Rush Medical Center, Meridian, MS, USA.ORCID https://orcid.org/0000-0001-5677-6420
Saleha AzizDepartment of Internal Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
Moon RyuDepartment of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
Asif FarooqDepartment of Family and Community Medicine, Texas Tech Health Sciences Center, Lubbock, TX, USA.
Karthik GanguDepartment of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Ehizogie EdiginDepartment of Rheumatology, Loma Linda University Health, Loma Linda, CA, USA.
Abu Baker SheikhDepartment of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
University of New Mexico · USJackson Memorial Hospital · USLoma Linda University · USTexas Tech University Health Sciences Center · USUniversity of Kansas Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is no uniformity in the available literature concerning the effects of coronavirus disease 2019 (COVID-19) viral illness on people with inflammatory bowel disease (IBD). Methods: We conducted an analysis using the 2020 National Inpatient Sample (NIS) database to compare the outcomes of COVID-19 hospitalized patients with and without IBD. Results: Of 1,050,040 patients admitted with COVID-19, 5,750 (0.5%) also had IBD. The group with COVID-19 and IBD had higher percentages of females and White individuals and a greater prevalence of chronic lung disease, peripheral vascular disease, and liver disease. However, after accounting for confounding variables, there was no significant difference in mortality rates, length of hospital stays, or hospitalization costs between the two groups. Conclusion: According to our findings, the presence of IBD does not appear to elevate the risk of COVID-19 complications.

Indexed as

Acute kidney injuryCOVID-19Gastrointestinal complicationsInflammatory bowel disease

Identifiers

PMID37937227
PMCPMC10627357
OpenAlexW4388049587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.